Recall Z-0132-2025— Medtronic Neuromodulation

Class II · Ongoing

Class II FDA medical device recall by Medtronic Neuromodulation, initiated 2024-08-21. FDA's recall record names no specific 510(k) clearance for this event. Product: Vanta Implantable Neurostimulator (INS), Model 977006. Reason: Model 977006 Vanta INS batterty life has depleted faster than HCPs or patients expected leading to outpatient reprogramming or earlier than anticipated surgical replacements..

Recalling firm
Medtronic Neuromodulation
Classification
Class II
Status
Ongoing
Initiated
2024-08-21
Firm location
Minneapolis, MN, United States

Product description

Vanta Implantable Neurostimulator (INS), Model 977006

Reason for recall

Model 977006 Vanta INS batterty life has depleted faster than HCPs or patients expected leading to outpatient reprogramming or earlier than anticipated surgical replacements.

Data sourced from openFDA. This site is unofficial and independent of the FDA.